🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Which P2Y12 inhibitor in older adults with #acutecoronarysyndrome? A network meta-analysis bit.ly/33xF9ei Stefan Agewall #EHJPharmacotherapy

DAPT or DPI in high risk CCS? A few differentiating aspects to aid decisions in patients at low bleeding risk: 1) prior stroke excluded in PEGASUS 2) longer time from MI in COMPASS, shorter in PEGASUS 3) primary results were driven by reduced MI in PEGASUS and stroke in COMPASS

Another gift of post COVID era ☹️ #complications #echofirst

Mechanistic evidence on myocardial injury in #COVID19. Published today in JACC Journals. Great collaboration between Milan and NYC. Gennaro Giustino, MD Humanitas Milano Mount Sinai Fuster Heart Hospital jacc.org/doi/10.1016/j.…

No difference in long-term mortality w/ #PCI vs. #CABG for left main #CAD Systematic review & meta-analysis: onlinelibrary.wiley.com/doi/full/10.10… Follow CCIjournal, facebook.com/CCIJournal Official Journal of SCAI

Today first patient randomized in Katowice! Ovidio De Filippo @MarioIannaccon8 Enrico Cerrato, MD, PhD Gianluca Campo Giorgio Quadri Università di Torino Federico Conrotto Fabrizio D'Ascenzo

PULSE PROTOCOL Angiographic control versus ischemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial openheart.bmj.com/content/7/2/e0…

PCRonline 🫀 David Hildick-Smith Join us to learn why stepwise provisional stenting as a logical, straightforward, reproducible, versatile strategy, & discuss if the second stent is a "complication" of provisional! Tom Johnson FRANCESCO BURZOTTA Manuel Pan Jens Flensted lassen Davide Capodanno Salvatore Brugaletta Mamas A. Mamas MIЯVΛƬ #IC

Among ACS patients with plaque erosion, presence of OCT-determined macrophages at culprit lesion is associated with more vulnerable plaque features and worse long-term prognosis (cardiac death&target-vessel revasc) Dr. Gustavo Montone European Atherosclerosis Society @Els_Cardiology atherosclerosis-journal.com/article/S0021-…

A concise and great update on the use of artificial intelligence in cardiology at Eur Heart J (free access). Not to be missed. bit.ly/3b69ypv #cardiotwitter PCRonline 🫀 European Society of Cardiology Journals EHJ Editor-in-Chief

Always check your coronary stent for damage after taking back out following crossing failure #CardioTwitter #RadialFirst EAPCIPresident Holger Nef Holger Thiele Mohamed Marwan @monique_trobs Dr Roxana Mehran MIЯVΛƬ #IC Mamas A. Mamas Gregg W. Stone MD European Society of Cardiology Javier Escaned

After 1 year 160 pts enrolled. Keep up the hard work! @MarioIannaccon8 Fabrizio D'Ascenzo Ovidio De Filippo Federico Conrotto Pierluigi Omedè Gianluca Campo Tebaldi Matteo guglielmo gallone Francesco Bruno Wojciech Wańha Enrico Cerrato, MD, PhD Giorgio Quadri

Does age affect outcomes after TAVR? The answer is SwissTAVI From JACC Journals - see jacc.org/doi/10.1016/j.…

STEMI after TAVI -33% longer door-to balloon time -Higher PCI failure, especially for CV and RCA -Very high in-hospital mortality An emerging issue when treating low-risk patients... Proud to be part of this international collaboration Fabrizio D'Ascenzo jacc.org/doi/10.1016/j.…

A true privilege performing the first world case with new generation coronary OCT, assisted with artificial intelligence, with Nieves Gonzalo at Hospital Clinico San Carlos / Madrid. PCRonline 🫀 Hemodinámica TCTMD #somosclinico Complutense